->->MC_ENG_DESKTOP/MC_ENG_NEWS/MC_ENG_BUSINESS_AS/MC_ENG_ROS_NWS_BUS_AS_ATF_728
Advertisement
Abbott India's shares initially struggled, but later gained ground on September 15th following the company's announcement that corrective measures were being taken at its Goa plant.
The stock was trading at Rs. 23,120, up 0.91 percent at 10:45 am, compared to its previous close. Earlier this morning, the stock had dipped to a low of Rs 22,911.25.
Earlier this month, regulator Drugs Controller General of India (DCGI) cautioned against the consumption of Digene Gel citing safety concerns. The drug maker had voluntarily recalled several batches of the medicine manufactured at the company’s Goa facility prior to the DCGI order. Abbott said that it is implementing corrective actions at its Goa facility on September 14.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Ayodhya Ram Mandir Live Updates: Pran Pratistha ceremony set to dazzle with bells, flowers, and musical harmony Watch more 
Stock Market LIVE Updates: Sensex, Nifty trade flat; auto stocks in fast lane Watch more Plain Fintech - RBI MPC Analysis | Eyes still fixed on inflation, but who is bearing the cost? Watch more Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Check your Free Credit Score now
